<DOC>
	<DOCNO>NCT02160990</DOCNO>
	<brief_summary>The overall goal study determine effect exenatide gastric emptying , satiety satiation obese participant . The hypothesis study exenatide retard gastric empty obese patient baseline accelerate gastric emptying .</brief_summary>
	<brief_title>Effect Exenatide Obese Patients With Accelerated Gastric Emptying</brief_title>
	<detailed_description>This study evaluate effect exenatide 5mcg subcutaneous ( SQ ) twice daily 30-days versus placebo gastric emptying , satiety , satiation weight loss obese participant document accelerated gastric empty solid . Visit 1 : Screening - physical exam , questionnaire , pregnancy test . Participants instruct continue diet exercise routine entire study . Visit 2 : Satiation Study Day - Subjects return clinic fasting least 8 hour . A baseline satiation/nutrient drink test perform Day 0 prior initiation exenatide placebo . The satiation/nutrient drink test involve drinking liquid meal ( Ensure ) rate one ounce per minute could ingest . At time , subject 's symptom record drank liquid meal 30 minute reach maximum volume tolerate . Subjects randomize exenatide placebo , receive 30 day ' supply blind study medication . Visit 3 : Satiation Study Day - ( This test perform last 5 day 30 day medication administration . ) Subjects return clinic fasting least 8 hour . Subjects instruct inject exenatide placebo 30 minute start satiation/nutrient drink test . The satiation/nutrient drink test repeat . Visit 4 : Gastric Emptying Scintigraphy Day - ( This test perform last 5 day 30 day medication administration . ) Subjects return clinic fasting least 8 hour . Subjects instruct inject exenatide placebo 30 minute start gastric empty test . Subjects give scramble egg breakfast toast glass milk . The eggs contain small amount radioactive substance . At completion breakfast test meal , subject instruct stand front special camera picture take specific interval . On day , subject participate eat meal . This meal consist lasagna , pudding , skim milk . Food container weigh meal calorie consume estimate use validated dietary software .</detailed_description>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Obese subject BMI &gt; 30 Kg/m^2 : Otherwise healthy individual currently treatment cardiac , pulmonary , gastrointestinal , hepatic , renal , hematological , neurological , endocrine ( hyperglycemia require medical therapy ) unstable psychiatric disease . Women childbearing potential negative pregnancy test initiation medication . Gastric empty ( GE ) : Accelerated GE T1/2 &lt; 79 minute GE 1h &gt; 35 % Type 1 type 2 diabetes mellitus diagnose accord American Diabetes Association criterion Unstable heart disease evidence ongoing angina Congestive heart failure Concomitant use appetite suppressant ( i.e. , caffeine base diethylpropion ) orlistat ( Xenical® ) Uncontrolled hypertension ( Blood pressure great 160/90 mmHg ) Use antidiabetic drug include metformin , History nephrolithiasis , Recurrent major depression , presence history suicidal behavior ideation intent act , current substantial depressive symptom ( Patient Health Questionnaire ( PHQ9 ) total score ≥10 ) . Gastroparesis Inflammatory bowel disease irritable bowel syndrome Malignancy treat chemotherapy within past 3 year History pancreatitis Renal insufficiency ( eGFR less 50 ml/min ) Concomitant use monoamine oxidase inhibitor ( i.e. , phenelzine , selegiline ) , serotonergic agent , centrally act appetite suppressant Significant psychiatric dysfunction base upon screen Hospital Anxiety Depression Scale ( HADS ) selfadministered alcoholism screen test ( SAAST , substance abuse ) questionnaire eat weight pattern ( binge eat disorder bulimia ) . If dysfunction identify HADS score ≥11 subscales difficulty substance eat disorder , participant exclude give referral letter his/her primary care doctor appraisal followup . Intake medication could interfere interpretation study cause drug interaction ( i.e. , ketoconazole , erythromycin ) . Specifically , birth control pill , estrogen replacement therapy , thyroxine replacement permissible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Obesity</keyword>
</DOC>